OasisLMS

The methods for AI-interpretation of electrocardiograms and other biosignatures are now well-established. However, implementing them in clinical practice is often an uphill battle. Cutting edge AI technologies that can predict incident atrial fibrillation or the onset of cardiomyopathy have tremendous value . . . but only if they are implemented and impact the patients they have been designed to help. This session moves beyond the individual AI-ECG tools and technologies themselves and focuses on how we can innovate care by putting these tools into everyday clinical practice. The session will foster a vibrant discussion of the challenges, opportunities, and best practices for bringing the power of AI-ECG technologies to all patients.